Related Experiment Video
Updated: Mar 2, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Mesenchymal stem cell therapy in type 2 diabetes mellitus
Li Zang1, Haojie Hao2, Jiejie Liu2
1Department of Endocrinology, Chinese PLA General Hospital, Beijing, 100853 China.
Abstract:
Type 2 diabetes mellitus (T2DM), which is characterized by the combination of relative insulin deficiency and insulin resistance, cannot be reversed with existing therapeutic strategies. Transplantation of insulin-producing cells (IPCs) was once thought to be the most promising strategy for treating diabetes, but the pace from the laboratory to clinical application has been obstructed due to its drawbacks. Mesenchymal stem cells (MSCs) harbor differentiation potential, immunosuppressive properties, and anti-inflammatory effects, and they are considered an ideal candidate cell type for treatment of DM. MSC-related research has demonstrated exciting therapeutic effects in glycemic control both in vivo and in vitro, and these results now have been translated into clinical practice. However, some critical potential problems have emerged from current clinical trials. Multi-center, large-scale, double-blind, and placebo-controlled studies with strict supervision are required before MSC transplantation can become a routine therapeutic approach for T2DM. We briefly review the molecular mechanism of MSC treatment for T2DM as well as the merits and drawbacks identified in current clinical trials.
Insights
Mesenchymal stem cells (MSCs) show promise for treating type 2 diabetes mellitus (T2DM) by improving glycemic control. However, further large-scale clinical trials are needed to establish MSC transplantation as a standard therapy for T2DM.
Area of Science:
- Regenerative Medicine
- Endocrinology
- Immunology
Background:
- Type 2 diabetes mellitus (T2DM) involves insulin deficiency and resistance, lacking curative treatments.
- Insulin-producing cell (IPC) transplantation, a potential diabetes therapy, faces clinical translation challenges.
- Mesenchymal stem cells (MSCs) possess differentiation, immunosuppressive, and anti-inflammatory properties, making them candidates for T2DM treatment.
Purpose of the Study:
- To review the molecular mechanisms of MSC treatment for T2DM.
- To evaluate the benefits and drawbacks of current MSC clinical trials for T2DM.
Main Methods:
- Review of existing literature on MSCs and T2DM.
- Analysis of in vitro and in vivo studies demonstrating MSC therapeutic effects.
- Examination of outcomes from current clinical trials involving MSC transplantation for T2DM.
Main Results:
- MSC research shows significant potential for improving glycemic control in T2DM.
- Current clinical trials indicate promising therapeutic effects of MSCs.
- Identified challenges and potential problems in existing clinical trials.
Conclusions:
- MSCs offer a promising cell-based therapy for T2DM due to their multifaceted properties.
- Rigorous, multi-center, large-scale, double-blind, placebo-controlled studies are essential.
- Further research and strict supervision are required before MSC transplantation becomes a routine T2DM treatment.
More Related Videos
10:50Author Spotlight: Isolation and Identification of Mesenchymal Stem Cells Derived from Adipose Tissue of Sprague Dawley Rats
Published on: April 7, 2023
08:09Isolation of Rat Adipose Tissue Mesenchymal Stem Cells for Differentiation into Insulin-producing Cells
Published on: August 29, 2022
Related Concept Videos
Mesenchymal Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Diabetes Mellitus: Type 2 and Gestational
Tissue Renewal without Stem Cells
However, failure of such a system...
Stem Cell Culture
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...